Report Detail

Pharma & Healthcare Global Alcohol Addiction Therapeutics Market Insights, Forecast to 2025

  • RnM2997265
  • |
  • 25 February, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Alcohol Addiction Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alcohol Addiction Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Alcohol Addiction Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alcohol Addiction Therapeutics in these regions.
This research report categorizes the global Alcohol Addiction Therapeutics market by top players/brands, region, type and end user. This report also studies the global Alcohol Addiction Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca Plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc

Market size by Product
CM-1212
CTDP-002
A-705253
ABT-436
ADX-71441
Others
Market size by End User
Hospital
Clinic
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Alcohol Addiction Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alcohol Addiction Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alcohol Addiction Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alcohol Addiction Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alcohol Addiction Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alcohol Addiction Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Alcohol Addiction Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Product
      • 1.4.2 CM-1212
      • 1.4.3 CTDP-002
      • 1.4.4 A-705253
      • 1.4.5 ABT-436
      • 1.4.6 ADX-71441
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Alcohol Addiction Therapeutics Market Size
      • 2.1.1 Global Alcohol Addiction Therapeutics Revenue 2014-2025
      • 2.1.2 Global Alcohol Addiction Therapeutics Sales 2014-2025
    • 2.2 Alcohol Addiction Therapeutics Growth Rate by Regions
      • 2.2.1 Global Alcohol Addiction Therapeutics Sales by Regions
      • 2.2.2 Global Alcohol Addiction Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Alcohol Addiction Therapeutics Sales by Manufacturers
      • 3.1.1 Alcohol Addiction Therapeutics Sales by Manufacturers
      • 3.1.2 Alcohol Addiction Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Alcohol Addiction Therapeutics Revenue by Manufacturers
      • 3.2.1 Alcohol Addiction Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Alcohol Addiction Therapeutics Price by Manufacturers
    • 3.4 Alcohol Addiction Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Alcohol Addiction Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Alcohol Addiction Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Alcohol Addiction Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Alcohol Addiction Therapeutics Sales by Product
    • 4.2 Global Alcohol Addiction Therapeutics Revenue by Product
    • 4.3 Alcohol Addiction Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Alcohol Addiction Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Alcohol Addiction Therapeutics by Countries
      • 6.1.1 North America Alcohol Addiction Therapeutics Sales by Countries
      • 6.1.2 North America Alcohol Addiction Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Alcohol Addiction Therapeutics by Product
    • 6.3 North America Alcohol Addiction Therapeutics by End User

    7 Europe

    • 7.1 Europe Alcohol Addiction Therapeutics by Countries
      • 7.1.1 Europe Alcohol Addiction Therapeutics Sales by Countries
      • 7.1.2 Europe Alcohol Addiction Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Alcohol Addiction Therapeutics by Product
    • 7.3 Europe Alcohol Addiction Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Alcohol Addiction Therapeutics by Countries
      • 8.1.1 Asia Pacific Alcohol Addiction Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Alcohol Addiction Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Alcohol Addiction Therapeutics by Product
    • 8.3 Asia Pacific Alcohol Addiction Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Alcohol Addiction Therapeutics by Countries
      • 9.1.1 Central & South America Alcohol Addiction Therapeutics Sales by Countries
      • 9.1.2 Central & South America Alcohol Addiction Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Alcohol Addiction Therapeutics by Product
    • 9.3 Central & South America Alcohol Addiction Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Alcohol Addiction Therapeutics by Countries
      • 10.1.1 Middle East and Africa Alcohol Addiction Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Alcohol Addiction Therapeutics by Product
    • 10.3 Middle East and Africa Alcohol Addiction Therapeutics by End User

    11 Company Profiles

    • 11.1 AstraZeneca Plc
      • 11.1.1 AstraZeneca Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Products Offered
      • 11.1.5 AstraZeneca Plc Recent Development
    • 11.2 BioCorRx Inc
      • 11.2.1 BioCorRx Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Products Offered
      • 11.2.5 BioCorRx Inc Recent Development
    • 11.3 Bionex Pharmaceuticals LLC
      • 11.3.1 Bionex Pharmaceuticals LLC Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Products Offered
      • 11.3.5 Bionex Pharmaceuticals LLC Recent Development
    • 11.4 Cerecor Inc
      • 11.4.1 Cerecor Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Cerecor Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Cerecor Inc Alcohol Addiction Therapeutics Products Offered
      • 11.4.5 Cerecor Inc Recent Development
    • 11.5 Chronos Therapeutics Ltd
      • 11.5.1 Chronos Therapeutics Ltd Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Products Offered
      • 11.5.5 Chronos Therapeutics Ltd Recent Development
    • 11.6 Corcept Therapeutics Inc
      • 11.6.1 Corcept Therapeutics Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Products Offered
      • 11.6.5 Corcept Therapeutics Inc Recent Development
    • 11.7 Curemark LLC
      • 11.7.1 Curemark LLC Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Curemark LLC Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Curemark LLC Alcohol Addiction Therapeutics Products Offered
      • 11.7.5 Curemark LLC Recent Development
    • 11.8 Eli Lilly and Company
      • 11.8.1 Eli Lilly and Company Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Products Offered
      • 11.8.5 Eli Lilly and Company Recent Development
    • 11.9 Ethypharm SA
      • 11.9.1 Ethypharm SA Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ethypharm SA Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ethypharm SA Alcohol Addiction Therapeutics Products Offered
      • 11.9.5 Ethypharm SA Recent Development
    • 11.10 H. Lundbeck A/S
      • 11.10.1 H. Lundbeck A/S Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Products Offered
      • 11.10.5 H. Lundbeck A/S Recent Development
    • 11.11 Heptares Therapeutics Ltd
    • 11.12 Indivior Plc
    • 11.13 Kinnov Therapeutics SAS
    • 11.14 Kyorin Pharmaceutical Co Ltd
    • 11.15 Lohocla Research Corp
    • 11.16 Montisera Ltd
    • 11.17 Omeros Corp
    • 11.18 Opiant Pharmaceuticals Inc

    12 Future Forecast

    • 12.1 Alcohol Addiction Therapeutics Market Forecast by Regions
      • 12.1.1 Global Alcohol Addiction Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Alcohol Addiction Therapeutics Market Forecast by Product
      • 12.2.1 Global Alcohol Addiction Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Alcohol Addiction Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Alcohol Addiction Therapeutics Market Forecast by End User
    • 12.4 North America Alcohol Addiction Therapeutics Forecast
    • 12.5 Europe Alcohol Addiction Therapeutics Forecast
    • 12.6 Asia Pacific Alcohol Addiction Therapeutics Forecast
    • 12.7 Central & South America Alcohol Addiction Therapeutics Forecast
    • 12.8 Middle East and Africa Alcohol Addiction Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Alcohol Addiction Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Alcohol Addiction Therapeutics . Industry analysis & Market Report on Alcohol Addiction Therapeutics is a syndicated market report, published as Global Alcohol Addiction Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Alcohol Addiction Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,611.40
      5,417.10
      7,222.80
      590,265.00
      885,397.50
      1,180,530.00
      325,260.00
      487,890.00
      650,520.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report